Biomedical subjects
Publications and source records attributed to C A McLaughlin.
A skin cancer screening programme involving 2150 employees based at the head office of a large UK retailer resulted in the detection of four melanomas at an early curable stage. In addition, three other malignant and three potentially malignant tumours were discovered, and individuals at greater risk of developing melanoma were identified and counselled accordingly.
Explore the source record for details and available documents.
The immune response of cattle to nonliving vaccines derived from Brucella abortus rough strain 45/20 was studied. Vaccines contained trehalose dimycolate and a derivative of muramyl dipeptide. N-acetylmuramyl-L-alpha-aminobutyryl-D-isoglutamine. A factorial experiment was designed to test the effects of type of antigen, quantity of antigen, and quantity of mineral oil on the immune response to porin. Muramyl dipeptide was kept constant at 5 mg per dose, and 1 part of trehalose dimycolate was incorporated for two parts of dry matter. Over a 10-week period, blastogenesis responses to porin were largest in cattle immunized with outer membranes; the highest antibody titers to the porin-lipopolysaccharide complex were achieved by immunization with detergent-extracted outer membrane proteins. There was no advantage in the use of 25, rather than 5, mg of any of the antigens, but antibody responses were improved by increasing the quantity of oil from 0.6 to 1.8 ml per dose. In other animals, blastogenesis and antibody responses were sustained at high levels longer than 3 months after two vaccinations with outer membrane proteins. Intradermal injection of porin evoked inflammatory reactions histologically consistent with delayed-type hypersensitivity. Cross-reactions in cases of delayed-type hypersensitivity occurred with porin derived from a smooth strain of B. abortus but were less extensive than in the blastogenesis test. The magnitude of the delayed-type hypersensitivity and blastogenesis responses induced by vaccination exceeded those observed after natural or experimental infections. No ill effects were observed after vaccination. These findings provide a basis for the use of trehalose dimycolate and muramyl dipeptide adjuvants in evaluating nonviable vaccines for bovine brucellosis.
We evaluated 1,266 persons who had received external radiotherapy for benign diseases in childhood. The evaluation used detailed questionnaires completed by trained interviewers and neoplastic disease registry data. The control population included 958 age-, sex-, race-, and disease-matched persons who had not received radiotherapy and 9,865 family members of the two study groups. An excess number of clinically important thyroid neoplasms, both benign and malignant, was noted in the irradiated group.
A high incidence of tumor regression was observed in guinea pigs bearing transplantable, line-10 hepatocellular carcinomas when synthetic muramyl dipeptides combined with trehalose dimycolate in oil-in-water emulsions were injected directly into the tumors. These compounds are promising candidates to replace viable bacillus Calmette-Guérin in cancer immunotherapy in humans and animals.
The capacity of trehalose dimycolate (TDM), muramyl dipeptide (MDP), and dimethyl dioctadecyl ammonium bromide (DDA)--alone or in combination--to potentiate the immunogenicity of killed Brucella abortus 45/20 bacteria was studied in guinea pigs. Bacterins that contained TDM in oil droplet emulsion were as effective in the prevention of brucellosis as those emulsified in Freund complete adjuvant, wereas bacterins that contained a combination of TDM and MDP were most effective. Vaccinal emulsions of bacteria and MDP were ineffective in the prevention of splenic infections. Likewise, DDA was unable to potentiate acquired resistance to Brucella. Addition of DDA to 1% oil emulsions of bacteria, TDM, and MDP eliminated protection. Adjuvants without bacteria were not able to nonspecifically protect animals from infection, although TDM was able to significantly reduce the numbers of splenic Brucella. A positive correlation (P < 0.0001) between splenic infection and splenic weight was found.
A purified protein derivative-live preparation of Brucella abortus strain 45/20 was tested for immunogenic properties either alone, after lipid conjugation, or in association with defined adjuvants. The adjuvants were trehalose dimycolate (cord factor), isolated from wax D of mycobacteria and murmyl dipeptide (N-acetyl-muramyl-L-alamyl-D-isoglutamine), a synthetic glycopeptide analog of peptidoglycan subunits found in many bacterial cell walls and wax D of mycobacteria. Guinea pigs were intradermally inoculated with a single injection of the vaccine preparations eight weeks before intramuscular challenge with B. abortus, strain 2308. None of the purified protein derivative-like preparations were as effective in the prevention of splenic infections with B. abortus as were killed whole cells of strain 45/20 in Freund's complete adjuvant. Whole cells in Freund's complete adjuvant were able to reduce mean colony counts by 97% (P = 0.02), while purified protein derivative-like vaccines were able to reduce mean colony counts by only 32 to 61% as compared to control animals. Results suggest that purified protein derivative-like preparations have limited immunogenic properties under present test conditions.
Whole cells of Brucella abortus strain 45/20 were combined with trehalose dimycolate or muramyl dipeptide. These preparations were tested in guinea pigs for immunogenic properties. Both trehalose dimycolate and muramyl dipeptide were found to be effective adjuvants to whole cells when combined in oil emulsions. Although saline suspensions of whole cells or whole cells-muramyl dipeptide did not significantly reduce splenic infections, oil emulsion or whole cells-trehalose dimycolate in oil droplet emulsion were both effective immunogens (P < 0.05). Oil emulsions of whole cells-muramyl dipeptide reduced mean splenic Brucella by 95.1% and those of whole cells-trehalose dimycolate reduced mean splenic Brucella by 99.3% as compared to the control animals.
A difficult secondary bilateral cleft lip deformity with nasal distortion was treated with eight local flaps specifically designed for this case. One of these was an Abbe flap in which the coronary vessel in the pedicle was inadvertently divided. The judgment in handling this flap and its fate as a composite lip flap based on a narrow mucosal pedicle is reported.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Intratumor chemotherapy with the use of mitomycin C and/or immunotherapy caused regression of line 10 carcinomas in strain 2 guinea pigs and resulted in development of tumor-specific immunity. The immunotherapeutic preparation consisted of oil-in-water emulsions containing Mycobacterium cell walls or residues of cell walls termed cell wall skeletons. The latter preparations were combined with trehalose dimycolate, which was isolated by microparticulate chromatography from whole cells of mycobacteria. Reducing mitomycin C to a single intratumor injection of 50 microgram produced little necrotizing effect and a mean tumor regression rate of 17%. Intratumor immunotherapy 1 day after treatment with 50 microgram of mitomycin C resulted in regression of 90% of the treated tumors as compared to mean regression rates of 30 to 50% for immunotherapy alone. In addition, chemoimmunotherapy was more effective than either chemotherapy or immunotherapy alone in producing regression of relatively large, as well as smaller, tumors.
Explore the source record for details and available documents.
A quantitative assay was developed to permit estimation of the relative amounts of albumin-synthesizing polyribosomes in rat liver. The polyribosomes synthesizing albumin were identified by their capacity to bind anti-RSA Fab' radiolabeled with 125I. The anti-RSA Fab'-binding sites occur on the nascent peptide chains attached to liver polyribosomes. These binding sites can be saturated by preincubation of the polyribosomes with large quantities of unlabeled anti-RSA Fab'. The iodinated antibody did not react with polyribosomes isolated from a tissue which does not synthesize rat serum albumin. Pretreatment of hepatic polyribosomes with bovine pancreatic ribonuclease resulted in a 42% enhancement of binding of anti-RSA Fab'. Pretreatment of these polyribosomes with detergents or various levels of Mg2+ did not significantly affect the specific binding of the iodinated antibody. Anti-RSA Fab' associated preferentially with membrane-bound polyribosomes when compared with free polyribosomes following their isolation from animals maintained either on a 90% or a 0% protein diet fed ad libitum. Binding of anti-RSA Fab' to each A260 unit of membrane-bound polyribosomes is from 2.4 to 27 times greater than to each A260 unit of free polyribosomes. However, each A260 unit of free polyribosomes was found to associate with 1.8 times more anti-RSA Fab' when compared with the "loosely bound" subclass of membrane-bound polyribosomes. Each A260 unit of the "tightly bound" subclass of membrane-bound polyribosomes reacted with 4.3 times as much antibody as compared with free polyribosomes. Polyribosomes isolated from the livers of rats sacrificed 6 h after treatment with actinomycin D showed a 42% reduction in their capacity to bind anti-RSA Fab'. Polyribosomes from rats sacrificed 2 h after treatment with actinomycin D showed no reduction in binding capacity. Free polyribosomes from three Morris hepatomas were capable of binding anti-RSA Fab' whereas the antibody would not associate with the membrane-bound polyribosomes of the same hepatomas. Thus the binding of 125I-labeled Fab' antibody molecules to polyribosomes is a useful technique for the subcellular localization of polyribosomes synthesizing specific proteins and for the estimation of the relative proportions of such polyribosomes.
With 125I-labeled Fab' specific for rat liver serine dehydratase it has been possible to localize polyribosomes synthesizing the enzyme under several different environmental conditions. Evidence is presented to show that, following the administration of amino acids in vivo, the relative synthetic capabilities of free and membrane-bound polyribosomes synthesizing serine dehydratase vary with time. Early during the period of induction of the enzyme by administration of amino acids or by feeding a high protein diet the majority of the newly synthesized enzyme is derived from membrane-bound polyribosomes. Later in the induction process an increasing proportion of the enzyme is synthesized by the free polyribosomes. Subcellular localization studies clearly show that serine dehydratase is synthesized by both subclasses of hepatic membrane-bound polyribosomes, the loose and tight membrane-bound polyribosomes, as well as by the free polyribosomes. It was found that the membrane-bound polyribosomes are the preferential sites of synthesis of the majority of serine dehydratase molecules in the Morris hepatomas 5123C and 7800. It is concluded that the synthesis of the enzyme, serine dehydratase, in rat liver is not discretely compartmentalized in either class of free or membrane-bound polyribosomes. Rather, the relative proportions of the serine dehydratase synthesizing polyribosomes within these two classes of polyribosomes can vary depending on the metabolic and physiologic state of the liver cell.
Smooth and rough endoplasmic reticulum from rat liver and hepatomas exhibited endogenous protein kinase activity independent of adenosine 3':5'-monophosphate. The phosphorylation of smooth membranes by this process was consistently higher than that of rough membranes. When histone was added along with the smooth endoplasmic reticulum, cyclic AMP stimulated protein phosphorylation. Analysis of membrane-phosphorylated proteins by gel electrophoresis showed 5 major phosphorylated bands with estimated molecular weights of 155 000, 62 000, 50 000, 46 000 and 43 000, whereas major bands having estimated molecular weights of 62 000, 50 000 and 43 000 were found in membranes of the smooth endoplasmic reticulum of the Morris hepatoma 5123 C. Since previous studies in this and other laboratories have demonstrated the similarity of the protein components of membranes of the endoplasmic reticulum of normal liver and hepatoma, our findings indicate an inability of the protein kinase of hepatoma intracellular membranes to phosphorylate protein species that are found in membranes of both liver and the neoplasm.
Explore the source record for details and available documents.